---
figid: PMC4623479__kcbt-16-01-987093-g006
figlink: /pmc/articles/PMC4623479/figure/f0006/
number: Figure 6
caption: (A)proposed mechanism of attenuated Proteasome Inhibitor-induced cytotoxicity
  in the multidrug-resistant MES-SA/Dx5 cancer cells Since MES-SA/Dx5 and the parental
  MES-SA cancer cells both trigger similar apoptosis pathway after MG132 or bortezomib
  treatment, MES-SA/Dx5 cells efflux MG132 or bortezomib out of the cell via ABCB1
  expression, resulting in reduced MG132 or bortezomib cytotoxicity. MES-SA/Dx5 cells
  then increase the expression of the cancer-cell growth factors cyclin D1 and c-Myc
  through the Wnt pathway to subsequently inhibit p21 regulation on the cell cycle.
  These events render MES-SA/Dx5 cells capable of resisting cell cycle suspension
  in the G2 phase caused by MG132 or bortezomib, permitting the cancer cells to proliferate
  normally and consequently alleviating proteasome Inhibitor cytotoxicity.
pmcid: PMC4623479
papertitle: Wnt pathway activation and ABCB1 expression account for attenuation of
  Proteasome inhibitor-mediated apoptosis in multidrug-resistant cancer cells.
reftext: Kowit Yu Chong, et al. Cancer Biol Ther. 2015 Jan;16(1):149-159.
pmc_ranked_result_index: '6413'
pathway_score: 0.9736857
filename: kcbt-16-01-987093-g006.jpg
figtitle: Wnt pathway activation and ABCB1 expression account for attenuation of Proteasome
  inhibitor-mediated apoptosis in multidrug-resistant cancer cells.
year: '2015'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4623479__kcbt-16-01-987093-g006.html
  '@type': Dataset
  description: (A)proposed mechanism of attenuated Proteasome Inhibitor-induced cytotoxicity
    in the multidrug-resistant MES-SA/Dx5 cancer cells Since MES-SA/Dx5 and the parental
    MES-SA cancer cells both trigger similar apoptosis pathway after MG132 or bortezomib
    treatment, MES-SA/Dx5 cells efflux MG132 or bortezomib out of the cell via ABCB1
    expression, resulting in reduced MG132 or bortezomib cytotoxicity. MES-SA/Dx5
    cells then increase the expression of the cancer-cell growth factors cyclin D1
    and c-Myc through the Wnt pathway to subsequently inhibit p21 regulation on the
    cell cycle. These events render MES-SA/Dx5 cells capable of resisting cell cycle
    suspension in the G2 phase caused by MG132 or bortezomib, permitting the cancer
    cells to proliferate normally and consequently alleviating proteasome Inhibitor
    cytotoxicity.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - PARP3
  - WNT5B
  - CTNNB1
  - WNT4
  - PARP1
  - PARP4
  - CASP6
  - CASP7
  - WNT3
  - WNT5A
  - WNT6
  - WNT3A
  - CASP10
  - TP53
  - PARP8
  - PARP2
  - CASP2
  - CASP3
  - CASP4
  - CASP5
  - WNT8B
  - WNT10B
  - WNT11
  - CASP8
  - CASP9
  - PARP11
  - CASP12
  - CASP14
  - CASP1
  - TNKS
  - WNT16
  - PARP10
  - WNT7A
  - PARP15
  - TIPARP
  - PARP14
  - PARP16
  - PARP6
  - WNT9A
  - MYC
  - WNT10A
  - PARP12
  - TNKS2
  - PARP9
  - WNT9B
  - WNT1
  - WNT2
  - WNT8A
  - WNT2B
  - WNT7B
  - Doxorubicin
genes:
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP3
  entrez: '10039'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT5B
  entrez: '81029'
- word: B-catenin
  symbol: beta-catenin
  source: hgnc_alias_symbol
  hgnc_symbol: CTNNB1
  entrez: '1499'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT4
  entrez: '54361'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP1
  entrez: '142'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP4
  entrez: '143'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP6
  entrez: '839'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP7
  entrez: '840'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT3
  entrez: '7473'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT5A
  entrez: '7474'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT6
  entrez: '7475'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT3A
  entrez: '89780'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP10
  entrez: '843'
- word: p53
  symbol: p53
  source: hgnc_alias_symbol
  hgnc_symbol: TP53
  entrez: '7157'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP8
  entrez: '79668'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP2
  entrez: '10038'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP2
  entrez: '835'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP3
  entrez: '836'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP4
  entrez: '837'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP5
  entrez: '838'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT8B
  entrez: '7479'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT10B
  entrez: '7480'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT11
  entrez: '7481'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP8
  entrez: '841'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP9
  entrez: '842'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP11
  entrez: '57097'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP12
  entrez: '100506742'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP14
  entrez: '23581'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP1
  entrez: '834'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: TNKS
  entrez: '8658'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT16
  entrez: '51384'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP10
  entrez: '84875'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT7A
  entrez: '7476'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP15
  entrez: '165631'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: TIPARP
  entrez: '25976'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP14
  entrez: '54625'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP16
  entrez: '54956'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP6
  entrez: '56965'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT9A
  entrez: '7483'
- word: c-Myc
  symbol: c-Myc
  source: hgnc_alias_symbol
  hgnc_symbol: MYC
  entrez: '4609'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT10A
  entrez: '80326'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP12
  entrez: '64761'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: TNKS2
  entrez: '80351'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP9
  entrez: '83666'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT9B
  entrez: '7484'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT1
  entrez: '7471'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT2
  entrez: '7472'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT8A
  entrez: '7478'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT2B
  entrez: '7482'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT7B
  entrez: '7477'
chemicals:
- word: Doxorubicin
  source: MESH
  identifier: D004317
diseases: []
---
